Celltrion | 068270 - 现金及等价物

金融业

KRW

KRW 759.44B

现金及等价物

KRW 49.87B

KRW 107.42B

KRW 470.6B

KRW 283.62B

KRW 161.31B

股息收益率

0.41

KRW 12.08B

KRW 17.79B

1.07K

EPS每股收益

KRW 1.58K

股本和储备

KRW 435.96B

KRW 46.98B

债务利息支出

KRW 19B

KRW 621.35M

KRW 412.27B

KRW 37265.39B

KRW 8.88B

KRW 140.68B

KRW 13.72B

普通股股本

KRW 218.61M

67.83

KRW 10.5B

KRW 1150B

销售和管理费用

KRW 12.71B

KRW 122.94B

贸易债权人

KRW 78.68B

应收帐款人

KRW 2049.53B

	现金及等价物	更改		日
Akebia Therapeutics	USD 162.64M		22.2M	2026-03
Alaunos Therapeutics	USD 354K		1.03M	2026-03
Avita Medical	AUD 10.24M		1.98M	2025-12
Celltrion	KRW 49.87B		20.22B	2025-12
Dianthus Therapeutics	USD 627.67M		576.58M	2026-03
Ionis Pharmaceuticals	USD 1.92B		758M	2026-03
IQVIA Holdings	USD 1.95B		33M	2026-03
Moderna	USD 1.91B		687M	2026-03
Organon & Co	USD 1.12B		542M	2026-03
Revvity	USD 860.32M		59.54M	2026-03
Tectonic Therapeutic	USD 236.89M		16.9M	2026-03
Viatris	USD 1.8B		481.8M	2026-03
Xeris Pharmaceuticals	USD 111.75M		708K	2026-03